Integrative Physiology |
From the Departments of Anesthesia and Critical Care (J.D.R., J.W., W.S., W.M.Z.) and Pediatrics (J.D.R.), the Cardiology Division of the Department of Medicine (K.D.B.), and the Cardiovascular Research Center (J.D.R., J.-D.C., K.D.B.), Harvard Medical School at Massachusetts General Hospital, Boston, Mass.
Correspondence to Jesse D. Roberts Jr, MD, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA 02114. E-mail roberts{at}cvrc.mgh.harvard.edu
AbstractVascular injury causes
the muscularization of peripheral pulmonary
arteries, which is more pronounced in the infant than in the adult
lung. Although inhaled NO gas attenuates pulmonary artery
remodeling in hypoxic rats, whether or not it protects the lung by
mitigating vasoconstriction is unknown. This investigation tested
whether inhaled NO decreases the muscularization of injured
pulmonary arteries in rat pups by modulating vascular tone. One
week after monocrotaline administration, the percentage of muscularized
rat pup lung arteries was increased by >3-fold. Nevertheless,
monocrotaline exposure did not cause right ventricular
hypertrophy, pulmonary hypertension, or
vasoconstriction. In addition, it did not increase the expression of
markers of inflammation (interleukin-1ß, intercellular adhesion
molecule-1, and E-selectin) or of platelet-mediated thrombosis
(GPIb
). Continuous inhalation of 20 ppm NO gas prevented the
neomuscularization of the pulmonary arteries in pups with lung
injury. Moreover, a 3-fold increase in cell proliferation and 30%
decrease in cell numbers in pulmonary arteries caused by
monocrotaline exposure was prevented by NO inhalation. These data
indicate that inhaled NO protects infants against pulmonary
remodeling induced by lung injury by mechanisms that are independent of
pulmonary tone, inflammation, or thrombosis.
(Circ Res. 2000;87:140-145.)
Key Words: inhaled nitric oxide pulmonary hypertension proliferation congenital heart disease bronchopulmonary dysplasia
This article has been cited by other articles:
![]() |
J. D. Roberts Jr., J.-D. Chiche, E. M. Kolpa, D. B. Bloch, and K. D. Bloch cGMP-dependent protein kinase I interacts with TRIM39R, a novel Rpp21 domain-containing TRIM protein Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L903 - L912. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Auten, S. N. Mason, M. H. Whorton, W. R. Lampe, W. M. Foster, R. N. Goldberg, B. Li, J. S. Stamler, and K. M. Auten Inhaled Ethyl Nitrite Prevents Hyperoxia-impaired Postnatal Alveolar Development in Newborn Rats Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Bloch, F. Ichinose, J. D. Roberts Jr., and W. M. Zapol Inhaled NO as a therapeutic agent Cardiovasc Res, July 15, 2007; 75(2): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakanishi, T. Sugiura, J. B. Streisand, S. M. Lonning, and J. D. Roberts Jr TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L151 - L161. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, H. Liu, G. Visner, and B. S. Fletcher Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats FASEB J, December 1, 2006; 20(14): 2594 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Brevnova, O. Platoshyn, S. Zhang, and J. X.-J. Yuan Overexpression of human KCNA5 increases IK(V) and enhances apoptosis Am J Physiol Cell Physiol, September 1, 2004; 287(3): C715 - C722. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ichinose, J. D. Roberts Jr, and W. M. Zapol Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential Circulation, June 29, 2004; 109(25): 3106 - 3111. [Full Text] [PDF] |
||||
![]() |
M. D. Schreiber, K. Gin-Mestan, J. D. Marks, D. Huo, G. Lee, and P. Srisuparp Inhaled Nitric Oxide in Premature Infants with the Respiratory Distress Syndrome N. Engl. J. Med., November 27, 2003; 349(22): 2099 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bland, C. Y. Ling, K. H. Albertine, D. P. Carlton, A. J. MacRitchie, R. W. Day, and M. J. Dahl Pulmonary vascular dysfunction in preterm lambs with chronic lung disease Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L76 - L85. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hellman, J. D. Roberts Jr., M. M. Tehan, J. E. Allaire, and H. S. Warren Bacterial Peptidoglycan-associated Lipoprotein Is Released into the Bloodstream in Gram-negative Sepsis and Causes Inflammation and Death in Mice J. Biol. Chem., April 12, 2002; 277(16): 14274 - 14280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Krick, O. Platoshyn, M. Sweeney, S. S. McDaniel, S. Zhang, L. J. Rubin, and J. X.-J. Yuan Nitric oxide induces apoptosis by activating K+ channels in pulmonary vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H184 - H193. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weinberger, D. L. Laskin, D. E. Heck, and J. D. Laskin The Toxicology of Inhaled Nitric Oxide Toxicol. Sci., January 1, 2001; 59(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |